Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. - Bräutigam, Jacqueline; Bischoff, Iris; Schürmann, Christoph; Buchmann, Giulia; Epah, Jeremy; Fuchs, Simone; Heiss, Elke; Brandes, Ralf P.; Fürst, Robert (Journal of Molecular & Cellular Cardiology, 2019)